Lymphoseek - direct healthcare professional communication (DHPC)

tilmanocept

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Lymphoseek (tilmanocept) 50 micrograms kit for radiopharmaceutical preparation: temporary extension of shelf life

Key facts

• Medicine name:
  Lymphoseek
• Active substance:
  tilmanocept
• Therapeutic area (MeSH):
  Radionuclide Imaging
• Procedure number:
  EMEA/H/C/002085
• Regulatory outcome:
  Maintenance
• DHPC type:
  Medicine shortage
• Human ATC codes:
  V09IA09
• Dissemination date:
  30/05/2022